Variables | (n = 48) |
---|---|
Age (years) | 64.3 ± 8.9 (39–80) |
Sex | |
Male | 42 (87.5%) |
Female | 6 (12.5%) |
Interval | |
< 5 years | 15 (31.3%) |
≥ 5, < 10 years | 15 (31.3%) |
≥ 10 years | 18 (37.5%) |
Total (months) | 105.6 ± 74.7 (14–350) |
Reconstruction method | |
Billroth I | 13 (27.1%) |
Billroth II | 35 (72.9%) |
Previous cancer stage | |
Stage I | 30 (62.5%) |
Stage II | 11 (22.9%) |
Stage III | 7 (14.6%) |
Previous PRM (cm) | |
< 3 | 9 (18.8%) |
≥ 3 | 39 (81.3%) |
Total | 5.9 ± 3.8 (0.5–20) |
Previous LI | |
Positive | 17 (35.4%) |
Negative | 31 (64.6%) |
Previous VI | |
Positive | 3 (6.3%) |
Negative | 45 (93.8%) |
Recurrence site | |
Non-anastomosis | 21 (43.8%) |
Anastomosis | 27 (56.3%) |
Differentiation | |
Differentiated | 21 (43.8%) |
Undifferentiated | 27 (56.3%) |
Lauren classification | |
Intestinal | 17 (35.4%) |
Diffuse | 18 (37.5%) |
Mixed | 13 (27.1%) |
RGC stage | |
Stage I | 24 (50%) |
Stage II | 12 (25%) |
Stage III | 12 (25%) |